Skin Treatment (Pharmacies) - North America

  • North America
  • Revenue in the Skin Treatment market is projected to reach US$3.81bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.60%, resulting in a market volume of US$4.77bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$3,319.00m in 2024).
  • In relation to total population figures, per person revenues of US$7.47 are generated in 2024.

Key regions: Germany, Europe, South Korea, France, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Skin Treatment (Pharmacies) market in North America is experiencing significant growth and development due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Skin Treatment (Pharmacies) market in North America are evolving as consumers become more conscious about their skin health. There is a growing demand for products that address specific skin concerns such as acne, aging, and hyperpigmentation. Customers are also seeking natural and organic skincare products that are free from harmful chemicals. In addition, there is a rising interest in cruelty-free and vegan skincare options. These customer preferences are driving the development of innovative and specialized skin treatment products in the market. Trends in the market are also contributing to the growth of the Skin Treatment (Pharmacies) market in North America. One prominent trend is the increasing popularity of multi-step skincare routines, inspired by Korean beauty practices. Customers are now incorporating multiple products into their daily skincare routines, including cleansers, toners, serums, moisturizers, and masks. This trend has led to an expansion of product offerings in the market, with pharmacies stocking a wide range of skincare products to cater to the diverse needs of customers. Another trend is the growing demand for personalized skincare solutions. Customers are seeking products that are tailored to their individual skin types and concerns, leading to the development of customizable skincare options. Local special circumstances also play a role in the development of the Skin Treatment (Pharmacies) market in North America. The region has a strong healthcare infrastructure, with well-established pharmacy chains that serve as convenient and accessible points of purchase for skincare products. Pharmacies in North America often have knowledgeable staff who can provide expert advice and recommendations to customers, further driving sales in the market. Additionally, the region has a diverse population with varying skincare needs, which creates opportunities for niche skincare products targeting specific ethnicities and skin types. Underlying macroeconomic factors are also contributing to the growth of the Skin Treatment (Pharmacies) market in North America. The region has a high disposable income, allowing customers to spend more on skincare products. The growing awareness of the importance of skincare and self-care has also led to increased spending in the market. Furthermore, the influence of social media and beauty influencers has created a demand for trendy and innovative skincare products, driving the growth of the market. In conclusion, the Skin Treatment (Pharmacies) market in North America is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As customers become more conscious about their skin health, there is a growing demand for specialized and personalized skincare products. Pharmacies in North America are capitalizing on this trend by offering a wide range of skincare options and providing expert advice to customers. The region's strong healthcare infrastructure, diverse population, high disposable income, and the influence of social media are also contributing to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)